Direktorat Registrasi ObatValid

ICLUSIG

BPOM Number: DKI2431500517A1
Approved: 28 November 2025
Expiry: 25 July 2029
Form: TABLET SALUT SELAPUT

About This Registration

ICLUSIG is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2431500517A1. Its current registration status is Valid, with the licence valid until 25 July 2029. The product is registered to OTSUKA INDONESIA - INDONESIA. BPOM first approved this registration in November 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 1 BOTOL PLASTIK @ 30 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

OTSUKA INDONESIA - INDONESIA
KAB. MALANG
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

OTSUKA INDONESIA - INDONESIA
KAB. MALANG
primary
View profile →

Ingredients (1)

PONATINIB HYDROCHLORIDE

Market Intelligence

Owner Portfolio: OTSUKA INDONESIA - INDONESIA holds 111 BPOM registrations
Manufacturer Scale: OTSUKA INDONESIA - INDONESIA produces 111 registered products
Registration Age: Registered for 7 months

FDA Cross-Reference

via openFDA

Generic Name: PONATINIB HYDROCHLORIDE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?